Social Stress Boosts Immune System's Flu-Fighting Abilities

A new study in mice suggests that, in certain cases, stress may enhance the body's ability to fight the flu.
Short bouts of intense social stress improved the ability in the mice to recover from the flu. The stress apparently did so by substantially boosting the production of specialized immune cells that fought the virus.
"Stressed mice had a stronger immune response and were able to fight off the infection faster," said Jacqueline Wiesehan, a study co-author and a graduate fellow in oral biology at Ohio State University.

These special immune cells are called T cells and are part of the immune system's memory response. T cells "remember" specific infectious agents and can launch future attacks against these intruders.

The researchers hope to learn more about the mechanisms behind the memory response, and to use this information to develop more effective flu vaccines in the future, said David Padgett, a study co-author and an associate professor of oral biology at Ohio State.

Wiesehan, Padgett and John Sheridan, the study's lead author and a professor of oral biology at Ohio State, presented their findings on April 3 at the Experimental Biology 2005 conference in San Diego. The three also worked on this study with Michael Bailey, a postdoctoral fellow in oral biology at Ohio State.

The immune system develops a memory response to the flu vaccine because the vaccine contains inactivated viral particles. The body responds by producing antibodies, special proteins that fight intruders, or antigens, such as bacteria and viruses. Sometimes, people who get the vaccine feel as if they actually have a mild case of the flu. They actually don't, Padgett said. Rather, those flu-like symptoms are just the body's response to making antibodies to the antigen.

New flu vaccines are created every year, and, according to the World Health Organization, are about 70 to 90 percent effective in preventing influenza.

"Right now, we try to vaccinate a large percentage of our elderly population in hopes of protecting most people from influenza," Padgett said. "But older adults may not get the same level of protection from the vaccine as younger adults would. We think that the memory response may be considerably different in older adults, whose immune systems generally don't work as well as a younger person's."

At the beginning of the study, some of the mice were caged in groups of three. One aggressive mouse, meant to disrupt the social environment in the cage, was put in each of thee cages for two hours at a time for six consecutive days.

At the end of the last stress session, the researchers infected both the subordinate mice that had endured stress and those mice that weren't caged with an aggressive mouse with a strain of influenza virus that can also infect humans. The mice were infected through their noses. This was the first time that the animals' immune systems had been exposed to the virus, and the researchers wanted to see what effect the stress would have on the immune system's memory response.

Three months later, the researchers injected either a small amount of saline solution or influenza virus into the footpad of one hind paw of each mouse. This kind of viral challenge caused what scientists call a "delayed-type hypersensitivity" response; the skin test routinely used to test a person for tuberculosis also causes this kind of response.

"It takes about a month for the body to develop a strong pool of memory T cells that are ready to fight another virus," Wiesehan said. "We waited a little longer to make sure this memory response was in place."

The influenza challenge caused the infected paws to redden and swell. The researchers measured the thickness of paws daily until the swelling went down – this measurement gave the researchers an idea of the number of cells responding to the viral antigen.

The affected paws of the stressed mice were noticeably more swollen than those of the non-stressed mice, suggesting that the immune system's of the stressed mice had had produced more immune cells that could respond to this strain of flu virus.

Three weeks later, the mice were re-infected with influenza virus through the nose. About a week later, the researchers examined the spleens and lungs from all of the mice. (Immune cells, including T cells, are activated in the spleen and lymph nodes, and then move to the lung cells where the flu virus has infected lung cells.)

The researchers measured the levels of flu-specific T cells in both organs, and found a greater number of the cells in both the spleens and lungs of the stressed mice.

While the mice in the study were re-infected with the identical strain of flu, there's a good chance that a person would not catch the same strain again, since flu viruses continually mutate.

Still, the T cells created during the initial infection can often respond to and attack variations of the same virus, Padgett said.

"Memory to a specific virus is considered life long, but the chance that someone will be re-infected with the same virus declines with time," he said. "Yet the antibodies that develop with the first illness can often recognize other, related strains."

The researchers now hope to figure out how the stressors affect memory response functions in people, particularly the elderly.

"If we can gain a solid understanding of how vaccines affect individual memory responses, we may be able to develop vaccines that elderly people could respond better to," Padgett said.

Curiously, similar work by Padgett, Sheridan and their Ohio State colleagues has shown that social stress can reactivate a latent herpes simplex virus type I in mice. HSV-1 causes cold sores around the mouth, and lesions on the face and genitals in humans.

"Social stress isn't necessarily a great thing," Padgett said. "But there must be some kind of adaptive advantage for this response – it seems to benefit the body by enhancing immune memory in some way.

"There may be some hormonal changes that actually promote the development of the memory T cells that are important in fighting of influenza," he continued. "The goal is to ultimately figure out what those changes are."

Source: Ohio State University

Related stories:

Mimic molecules to protect against plague
Bacteria that cause pneumonic plague can evade our first-line defences, making it difficult for the body to fight infection. In fact, a signature of the plague is the lack of an inflammatory response. Now, scientists have discovered a way to protect against death following infection with plague bacteria, by using molecules that can mimic the pathogens. According to research published in the July issue of Microbiology, these molecules make antibiotics more effective and can even be used to protect against other diseases.
Parasite vaccines within reach
Even though parasites are complex creatures, the mammalian immune response to them is surprisingly simple, leading University of California, Berkeley, researchers to predict that creating vaccines for parasitic diseases such as malaria may be more straightforward than initially thought.
Penn animal study identifies new DNA weapon against avian flu
Researchers at the University of Pennsylvania School of Medicine have identified a potential new way to vaccinate against avian flu. By delivering vaccine via DNA constructed to build antigens against flu, along with a minute electric pulse, researchers have immunized experimental animals against various strains of the virus. This approach could allow for the build up of vaccine reserves that could be easily and effectively dispensed in case of an epidemic. This study was published last week in PLoS ONE.
Small protein may have big role in making more bone and less fat
A small protein may have a big role in helping you make more bone and less fat, researchers say. "The pathways are parallel, and the idea is if you can somehow disrupt the fat production pathway, you will get more bone," says Dr. Xingming Shi, bone biologist at the Medical College of Georgia Institute of Molecular Medicine and Genetics.
Best treatment for MS may depend on disease subtype
Animal studies by University of Michigan scientists suggest that people who experience the same clinical signs of multiple sclerosis (MS) may have different forms of the disease that require different kinds of treatment.
Cancer cells revert to normal at specific signal threshold, researchers find
Cancer starts when key cellular signals run amok, driving uncontrolled cell growth. But scientists at the Stanford University School of Medicine report that lowering levels of one cancer signal under a specific threshold reverses this process in mice, returning tumor cells to their normal, healthy state. The finding could help target cancer chemotherapy to tumors while minimizing side effects for the body's healthy cells.
Wake up and smell the coffee: Study finds that caffeine may help prevent MS
A good cup of coffee might be just the wake-up call scientists need to stop multiple sclerosis.
Reprogramming Adult Stem Cells in the Brain
In recent years, stem cell researchers have become very adept at manipulating the fate of adult stem cells cultured in the lab. Now, researchers at the Salk Institute for Biological Studies achieved the same feat with adult neural stem cells still in place in the brain. They successfully coaxed mouse brain stem cells bound to join the neuronal network to differentiate into support cells instead.

News discussion:

General Science news